ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ESMO 2024
04:52

ecancer

ESMO 2024 Insights: GigaPath AI Model - Cancer Mutation Prediction Using Artificial Intelligence

FEATURING Carlo B. Bifulco
  • 13 views
  • October 22, 2024
17:44

ecancer

ESMO 2024: Optimizing the Personalization of Prostate Cancer Treatment

FEATURING Alison Birtle, Alejo RodríGuez-Vida, Pasquale Rescigno, Gunhild von Amsberg
  • 48 views
  • October 22, 2024
05:16

ecancer

ESMO 2024 Insights: ROME Basket Trial - Targeting Actionable Mutations vs. SoC in Pts With Advanced Solid Tumors

FEATURING Andrea Botticelli
  • 15 views
  • October 22, 2024
24:59

ecancer

ESMO 2024: Latest in Bladder Cancer - Expert Review

FEATURING Patrizia Giannatempo, Andrea Necchi, Simon Crabb, Michiel Simon Van Der Heijden
  • 28 views
  • October 22, 2024
24:24

ecancer

ESMO 2024 Summary: Highlights & Analysis of the Biggest Solid Cancer Updates

FEATURING Bishal Gyawali
  • 44 views
  • October 21, 2024
04:08

ecancer

ESMO 2024 Insights: SUNNIFORECAST Trial - Nivo + Ipi vs. Standard of Care in Non-Clear-Cell RCCs

FEATURING Lothar Bergmann
  • 10 views
  • October 16, 2024
04:19

ecancer

ESMO 2024 Insights: JCOG1019 Study - Watchful Waiting vs. Intravesical BCG in HGT1 Bladder Cancer

FEATURING Hiroshi Kitamura
  • 41 views
  • October 16, 2024
  • 1
21:42

ecancer

ESMO 2024 Insights: Best Practice in HRRm Testing in Patients With Metastatic Prostate Cancer

FEATURING Karim Fizazi, Anders Bjartell, Niven Mehra, Eleni Efstathiou
  • 94 views
  • October 16, 2024
08:59

ecancer

ESMO 2024 Insights: EA3163 Trial - Chemo Followed by Surgery & PORT vs. Surgery & PORT for Organ Preservation of T3 & T4a (Selected T4b) Sinonasal Squamous Cell Carcinoma

FEATURING Nabil Saba
  • 82 views
  • October 14, 2024
06:14

ecancer

ESMO 2024 Insights: NADINA Trial - Neoadjuvant Ipi Added to Nivo in Resectable Advanced Melanoma

FEATURING Minke Lucas
  • 27 views
  • October 14, 2024
06:35

ecancer

ESMO 2024 Insights: Novel ADC TORL-1-23 in Heavily-Pretreated Ovarian, Endometrial, and Testicular Cancers

FEATURING Gottfried Konecny
  • 47 views
  • October 14, 2024
06:02

ecancer

ESMO 2024 Insights: PRIMA Trial - Newly Diagnosed Advanced Ovarian Cancer Treated With Niraparib for 1L Maintenance

FEATURING Antonio González-Martín
  • 153 views
  • October 14, 2024
  • 1
04:15

ecancer

ESMO 2024 Insights: NO-CUT Trial - Total Neoadjuvant Treatment Without Surgery for Locally Advanced Rectal Cancer

FEATURING Alessio Amatu
  • 188 views
  • October 14, 2024
  • 1
18:44

ecancer

ESMO 2024 Summary: Understanding the Use of PARPi Combinations to Treat Patients With mCRPC

FEATURING Axel Merseburger, Friederike Schlürmann, Elena Castro, Gerhardt Attard
  • 25 views
  • October 11, 2024
05:32

ecancer

ESMO 2024 Insights: PEACE-3 Trial - Enzalutamide Treatment Boosted by Radium-223 in mCRPC

FEATURING Silke Gillessen
  • 57 views
  • October 11, 2024
18:36

ecancer

ESMO 2024 Summary: Latest Updates in mRCC

FEATURING Javier Puente, Guillermo de Velasco, Cristina Suárez, Stéphane Oudard
  • 75 views
  • October 11, 2024
05:10

ecancer

ESMO 2024 Insights: PIONeeR Trial - IO Resistance Pathways Investigated to Tailor Combination Advanced NSCLC Therapy

FEATURING Pascale Tomasini
  • 28 views
  • October 11, 2024
19:15

ecancer

ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON, REZILIENT1, LAURA, and SKIPPirr

FEATURING Ignacio Gil-Bazo, Mariana Brandão, Benjamin Besse, Enriqueta Felip
  • 266 views
  • October 11, 2024
  • 1
06:35

ecancer

ESMO 2024 Insights: Canadian Cancer Trials Group BR.31 Study - Adjuvant Durvalumab After Complete Tumor Resection & Optional Chemo in Early Stage (IB-IIIA) NSCLC

FEATURING Glenwood Goss
  • 24 views
  • October 11, 2024
05:58

ecancer

ESMO 2024 Insights: WSG-TP-II Trial - ET + Trastuzumab & Pertuzumab vs. De-Escalated Chemo + Trastuzumab & Pertuzumab in HR+/HER2+ eBC

FEATURING Oleg Gluz
  • 43 views
  • October 11, 2024
  • 1
04:16

ecancer

ESMO 2024 Insights: Neo-CheckRay Trial - Durvalumab & Oleclumab Boost for SBRT + Chemo in ER+/HER2- eBC

FEATURING Alex De Caluwe
  • 16 views
  • October 11, 2024